Product Information

METFORMIN HCL 500 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0142 per EA under NDC 82009004610. Its NADAC has been published 177 times since Apr 5, 2023.

FDA first approved this application on Apr 22, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METFORMIN HCL 500 MG TABLET

Metformin Hydrochloride Tablet
$0.0142per EA

Strength

500 mg/1

NDC

82009004610

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090564

FDA Approved

4/22/2010

TE Code

AB

On Market Since

2/1/2022

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN HCL 500 MG TABLET has been published 177 times since Apr 5, 2023, and over the history we have for it it has declined 14.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0142 per EA
All-time high$0.0168 (Dec 13, 2023)
All-time low$0.0123 (Nov 20, 2024)
52-week high$0.0147
52-week low$0.0139
Median price$0.0143
Average price$0.0146
Largest weekly change+20.4% (Jun 19, 2024)
Weeks tracked177
Tracking sinceApr 5, 2023

Price History

1W

+0.9%

1M

+0.9%

3M

+1.6%

6M

+1.7%

1Y

-1.5%

3Y

-11.8%

5Y

N/A

All

-14.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Metformin Hydrochloride Tablet market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of METFORMIN HCL 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 500 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0142 per EA (NDC 82009004610), effective Aug 19, 2026.

How has the price of METFORMIN HCL 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for METFORMIN HCL 500 MG TABLET has declined 14.4%. It has been tracked across 177 weekly CMS publications since Apr 5, 2023.

What are the highest and lowest recorded NADAC prices for METFORMIN HCL 500 MG TABLET?

Since Apr 5, 2023, the NADAC for METFORMIN HCL 500 MG TABLET has ranged from a low of $0.0123 (Nov 20, 2024) to a high of $0.0168 (Dec 13, 2023), with a median of $0.0143 per EA.

Are there cheaper alternatives to METFORMIN HCL 500 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of METFORMIN HCL 500 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METFORMIN HCL 500 MG TABLET?

METFORMIN HCL 500 MG TABLET (NDC 82009004610) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.